InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Campoy Carlos, Chief Financial Officer. Insider active across 1 companies, notably CytomX Therapeutics, Inc.. Cumulatively, 4 reports have been published. The latest transaction was filed on 2 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations4 total
022,500 shares0
Common Stock
SEC:0001567619-22-002522·
022,500 shares0
Common Stock
SEC:0001567619-22-002522:0·
€16,5173,320 shares@ €4.97510.0023% mcap100.0% of flow
Common Stock
SEC:0001567619-21-011807·
€16,5173,320 shares@ €4.97510.0023% mcap50.0% of flow
Common Stock
SEC:0001567619-21-011807:0·
4 of 4 declarations
About Campoy Carlos
Carlos Campoy is the Chief Financial Officer of CytomX Therapeutics, Inc. In this role, he is responsible for the financial management of the company, including financial planning, risk management, and regulatory compliance. Campoy works closely with management to ensure the financial health of the company and support its growth strategy.
